Worth Seeing!
Seeking Stock Market Success? Forget the Hype, Build a Solid Foundation. Find Now Find Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 73885.60
617.3 (-0.83%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Syncom Formulations (India) Ltd.
1,168
(Small Cap)
12.39
(-0.32%)
49.46
4.08
7.21
10.35
Q V+ PT
2
Morepen Laboratories Ltd.
2,399
(Small Cap)
46.47
(-1.00%)
21.63
2.7
19.01
9.18
Q V PT
3
Sigachi Industries Ltd.
2,167
(Small Cap)
63.79
(-3.41%)
52.85
5.28
23.28
32.58
Q V+ PT
4
KMC Speciality Hospitals (India) Ltd.
1,399
(Small Cap)
83.96
(-2.14%)
N/A
N/A
17.12
31.95
Q V PT
5
Suven Life Sciences Ltd.
2,102
(Small Cap)
95.05
(-1.40%)
N/A
2.49
-53.54
-163.87
Q V PT
6
Bliss GVS Pharma Ltd.
1,084
(Small Cap)
102.80
(-0.68%)
21.41
1.1
14.97
1.73
Q V+ PT
7
Sequent Scientific Ltd.
2,621
(Small Cap)
103.05
(-1.90%)
N/A
3.99
10.88
-288.40
Q V PT
8
Panacea Biotec Ltd.
825
(Small Cap)
132.40
(-1.67%)
N/A
2.49
-14.85
0.00
Q V PT
9
Piramal Pharma Ltd.
19,880
(Small Cap)
145.65
(-2.87%)
50.81
2.96
0.00
0.00
Q V PT
10
Marksans Pharma Ltd.
7,674
(Small Cap)
147.40
(-12.96%)
64.72
6.45
17.33
59.01
Q V PT
11
Artemis Medicare Services Ltd.
2,430
(Small Cap)
176.70
(-0.42%)
49.43
6.33
7.28
17.28
Q V+ PT
12
Dishman Carbogen Amcis Ltd.
3,024
(Small Cap)
187.40
(-2.83%)
N/A
0.53
7.32
-23.69
Q V PT
13
SMS Pharmaceuticals Ltd.
1,789
(Small Cap)
198.65
(-6.01%)
43.03
3.4
2.34
-48.56
Q V+ PT
14
Themis Medicare Ltd.
1,891
(Small Cap)
206.10
(0.29%)
76.43
7.06
11.08
34.06
Q V+ PT
15
Sun Pharma Advanced Research Company Ltd.
6,872
(Small Cap)
206.65
(-2.41%)
N/A
55.04
24.99
0.00
Q V+ PT
16
Indraprastha Medical Corporation Ltd.
2,176
(Small Cap)
226
(-4.78%)
17.55
4.55
7.86
31.45
Q V+ PT
17
Kopran Ltd.
1,113
(Small Cap)
226.50
(-1.91%)
32.14
2.67
12.18
217.28
Q V PT
18
Shalby Ltd.
2,929
(Small Cap)
265.15
(-2.23%)
28.21
2.82
13.24
14.33
Q V PT
19
Hikal Ltd.
3,575
(Small Cap)
286
(-1.36%)
51.37
3.01
9.31
-0.88
Q V PT
20
Bajaj Healthcare Ltd.
816
(Small Cap)
291
(-1.59%)
N/A
2.93
18.39
25.96
Q V PT
21
Indoco Remedies Ltd.
2,879
(Small Cap)
308.45
(-1.23%)
24.68
2.56
9.93
28.74
Q V+ PT
22
Biocon Ltd.
38,851
(Mid Cap)
310.80
(-3.96%)
325.66
3.56
-3.80
31.80
Q V PT
23
Gufic Biosciences Ltd.
3,214
(Small Cap)
311.55
(-2.79%)
38.17
6.27
17.71
34.15
Q V PT
24
Sastasundar Ventures Ltd.
1,062
(Small Cap)
324.85
(-2.74%)
N/A
3.9
-100.00
-43.78
Q V+ PT
25
Jagsonpal Pharmaceuticals Ltd.
905
(Small Cap)
330
(-3.62%)
40.3
4.83
13.35
0.00
Q V+ PT
26
Supriya Lifescience Ltd.
2,794
(Small Cap)
347.10
(-0.03%)
23.46
3.57
16.71
67.00
Q V+ PT
27
Aster DM Healthcare Ltd.
18,247
(Small Cap)
355.85
(-2.59%)
141.14
3.97
12.17
15.37
Q V+ PT
28
Healthcare Global Enterprises Ltd.
5,028
(Small Cap)
359.55
(-0.40%)
126.02
4.24
11.39
7.94
Q V PT
29
IOL Chemicals And Pharmaceuticals Ltd.
2,142
(Small Cap)
359.55
(-1.48%)
15.94
1.33
0.00
0.00
Q V+ PT
30
Advanced Enzyme Technologies Ltd.
4,028
(Small Cap)
362.90
(0.75%)
37.25
6.94
8.00
9.23
Q V PT
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Glaxosmithkline Phar
2,5932.22%
Neuland Laboratories
6,195.201.90%
Narayana Hrudayalay
1,169.201.85%
Tarsons Products
424.251.27%
Jupiter Life Line
1,168.601.17%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Marksans Pharma
147.40-12.96%
Medicamen Biotech
477-6.13%
SMS Pharmaceuticals
198.65-6.01%
Alkem Laboratories
4,951.90-5.95%
Wockhardt
537.05-5%
View More

News about Top Pharma Companies in India

Marksans Pharma reports 6% fall in Q4 consolidated net profit

Total consolidated income of the company increased by 16.01% at Rs 576.54 crore for Q4FY24
30 May, 2024

Sequent Scientific informs about compliance report

Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, Sequent Scientific has informed that it enclosed Annual Secretarial Compliance Report of the company issued by Nilesh Shah & Associates, Practicing Company Secretaries, for the year ended March 31, 2024.

The above information is a part of company’s filings submitted to BSE.

30 May, 2024

HealthCare Global Enterprises informs about press release

HealthCare Global Enterprises has informed that the Board of Directors of the Company, at their meeting held on May 29, 2024, has approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024 (‘Financial Results’). In this respect, it has enclosed the communication being released to the Press on the Financial Results of the Company.

The above information is a part of company’s filings submitted to BSE.

30 May, 2024

Aster DM Healthcare - Quaterly Results

The sales for the March 2024 quarter moved up 27.03% to Rs. 5455.60 millions as compared to Rs. 4294.60 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2024 is Rs. -81.10 millions as compared to Net Profit of Rs. 518.70 millions of corresponding quarter ended March 2023Operating Profit saw a handsome growth to 1032.20 millions from 976.90 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5455.60 4294.60 27.03 20365.00 15337.40 32.78 20365.00 15337.40 32.78
Other Income 37.20 122.30 -69.58 490.20 497.70 -1.51 490.20 497.70 -1.51
PBIDT 1032.20 976.90 5.66 4091.00 3381.60 20.98 4091.00 3381.60 20.98
Interest 209.20 145.80 43.48 783.70 518.10 51.26 783.70 518.10 51.26
PBDT 823.00 831.10 -0.97 3307.30 2863.50 15.50 3307.30 2863.50 15.50
Depreciation 356.50 290.60 22.68 1213.80 1040.20 16.69 1213.80 1040.20 16.69
PBT 466.50 540.50 -13.69 2093.50 1823.30 14.82 2093.50 1823.30 14.82
TAX 547.60 21.80 2411.93 523.90 90.40 479.54 523.90 90.40 479.54
Deferred Tax 778.10 -74.70 -1141.63 523.90 -238.80 -319.39 523.90 -238.80 -319.39
PAT -81.10 518.70 -115.64 1569.60 1732.90 -9.42 1569.60 1732.90 -9.42
Equity 4995.20 4995.20 0.00 4995.20 4995.20 0.00 4995.20 4995.20 0.00
PBIDTM(%) 18.92 22.75 -16.82 20.09 22.05 -8.89 20.09 22.05 -8.89
28 May, 2024

Supriya Lifescience - Quaterly Results

The March 2024 quarter revenue stood at Rs. 1581.80 millions, up 11.18% as compared to Rs. 1422.70 millions during the corresponding quarter last year.Net profit declined -3.40% to Rs. 369.31 millions from Rs. 382.29 millions.OP of the company witnessed a marginal growth to 576.89 millions from 570.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1581.80 1422.70 11.18 5703.70 4609.38 23.74 5703.70 4609.38 23.74
Other Income 21.85 19.64 11.25 106.35 94.89 12.08 106.35 94.89 12.08
PBIDT 576.89 570.10 1.19 1836.11 1383.87 32.68 1836.11 1383.87 32.68
Interest 6.01 7.14 -15.83 21.10 30.84 -31.58 21.10 30.84 -31.58
PBDT 570.88 562.96 1.41 1815.01 1353.03 34.14 1815.01 1353.03 34.14
Depreciation 39.14 30.07 30.16 158.11 118.15 33.82 158.11 118.15 33.82
PBT 531.74 532.89 -0.22 1656.90 1234.88 34.17 1656.90 1234.88 34.17
TAX 162.43 150.60 7.86 465.76 336.30 38.50 465.76 336.30 38.50
Deferred Tax 72.99 18.53 293.90 94.76 29.49 221.33 94.76 29.49 221.33
PAT 369.31 382.29 -3.40 1191.14 898.58 32.56 1191.14 898.58 32.56
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 36.47 40.07 -8.99 32.19 30.02 7.22 32.19 30.02 7.22
28 May, 2024

Shalby - Quaterly Results

A fair growth of 16.29% in the revenue at Rs. 2063.23 millions was reported in the March 2024 quarter as compared to Rs. 1774.14 millions during year-ago period.Modest increase of 22.92% in the Net Profit was reported from. 183.54 millions to Rs. 225.60  millions.Operating profit for the quarter ended March 2024 rose to 426.31 millions as compared to 364.83 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2063.23 1774.14 16.29 8296.83 7080.17 17.18 8296.83 7080.17 17.18
Other Income 43.74 65.52 -33.24 207.04 195.66 5.82 207.04 195.66 5.82
PBIDT 426.31 364.83 16.85 1982.74 1615.20 22.76 1982.74 1615.20 22.76
Interest 9.92 6.94 42.94 28.86 31.01 -6.93 28.86 31.01 -6.93
PBDT 416.39 357.89 16.35 1953.88 1584.19 23.34 1953.88 1584.19 23.34
Depreciation 91.22 92.96 -1.87 370.76 370.64 0.03 370.76 370.64 0.03
PBT 325.17 264.93 22.74 1583.12 1213.55 30.45 1583.12 1213.55 30.45
TAX 99.57 81.39 22.34 544.67 405.48 34.33 544.67 405.48 34.33
Deferred Tax -20.24 -21.69 -6.69 -48.70 61.23 -179.54 -48.70 61.23 -179.54
PAT 225.60 183.54 22.92 1038.45 808.07 28.51 1038.45 808.07 28.51
Equity 1074.13 1073.10 0.10 1073.10 1073.10 0.00 1073.10 1073.10 0.00
PBIDTM(%) 20.66 20.56 0.48 23.90 22.81 4.75 23.90 22.81 4.75
28 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Syncom Formulations (India) Ltd. 1,168 Crore
2 Morepen Laboratories Ltd. 2,399 Crore
3 Sigachi Industries Ltd. 2,167 Crore
4 KMC Speciality Hospitals (India) Ltd. 1,399 Crore
5 Suven Life Sciences Ltd. 2,102 Crore
6 Bliss GVS Pharma Ltd. 1,084 Crore
7 Sequent Scientific Ltd. 2,621 Crore
8 Panacea Biotec Ltd. 825 Crore
9 Piramal Pharma Ltd. 19,880 Crore
10 Marksans Pharma Ltd. 7,674 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,430 19,811 36.06 18.28 23.13 51.69
Abbott India Ltd. (M) Very Good 25,919 55,456 46.17 14.99 31.34 31.69
Laurus Labs Ltd. (S) Very Good 429.4 23,730 147.8 5.77 32.46 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,877 1,00,086 17.94 3.54 11.33 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,664 91,893 55.49 13.40 27.73 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Gland Pharma Ltd. (M) Very Good 1,857 30,630 103.7
Zydus Lifesciences Ltd. (L) Very Good 1,025 1,05,162 102.4
Lupin Ltd. (M) Somewhat Good 1,577 72,999 96.31
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 1,157 33,287 93.95
Aurobindo Pharma Ltd. (M) Very Good 1,207 71,385 84.44
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 429.4 23,730 147.8 5.77 32.46 24.05
Granules India Ltd. (S) Somewhat Good 424.1 10,415 23.89 3.35 13.93 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,744 27,450 50.52 9.51 30.33 18.11
Gland Pharma Ltd. (M) Very Good 1,857 30,630 29.36 3.41 18.43 17.42
Mankind Pharma Ltd. (L) Very Good 2,098 84,248 46.20 8.75 32.21 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 429.4 23,730 147.8 5.77 32.46 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,877 1,00,086 17.94 3.54 11.33 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,744 27,450 50.52 9.51 30.33 31.92
Biocon Ltd. (M) Somewhat Good 310.8 38,851 325.7 3.56 88.45 31.80
Granules India Ltd. (S) Somewhat Good 424.1 10,415 23.89 3.35 13.93 31.51
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.